- Understanding the Scaled Score of 500
- Exam Structure: 245 Questions, Six Sections
- How Domain Weighting Shapes the Passing Threshold
- What Recent Pass Rates Suggest About the Standard
- Question Formats That Cost Points
- Allocating Study Time Around the Scaled Score
- Registration, Fees, and Test-Day Mechanics
- Frequently Asked Questions
- Passing requires a scaled score of 500, not a fixed raw percentage of 245 questions.
- Solid Tumors (11%), Inherited Diseases (10%), and Hematopathology (9%) carry the most scoring weight.
- In 2025, 50 of 56 examinees passed overall (89%); first-time takers passed at 92% (45 of 49).
- The exam runs 6 hours 34 minutes of active testing inside a 9 hour 4 minute scheduled day.
Understanding the Scaled Score of 500
One of the most misunderstood aspects of the Molecular Genetic Pathology (MGP) certification exam is how the American Board of Pathology (ABPath) actually decides who passes. There is no published cutoff like "you need 70% correct." Instead, ABPath converts raw performance into a scaled score, and the passing standard is set at 500. This is a fixed reference point on ABPath's scaling system, not a percentage of the 245 questions on the 2026 form.
Scaled scoring exists so that difficulty differences between exam forms don't unfairly help or hurt any single cohort. If one year's form leans slightly harder on Techniques and Methods or Assay Performance and Validation, the scaling adjustment accounts for that, and 500 remains the line between pass and fail regardless of which version a candidate sees. For candidates, the practical implication is simple: you cannot reverse-engineer "how many questions you can miss" with any precision, because ABPath does not publish a raw-to-scaled conversion table.
Exam Structure: 245 Questions, Six Sections
The 2026 MGP examination schedule contains 245 single-best-answer multiple-choice questions distributed across six sections. Total active testing time is 6 hours 34 minutes, while the full scheduled day - including check-in, instructions, a survey, and scheduled breaks - runs 9 hours 4 minutes. This is a computer-based exam administered in person at Pearson VUE Professional Centers; it is not offered as a remotely proctored at-home test.
Some questions include written or practical material - meaning you should expect to interpret molecular laboratory data, sequence traces, array findings, karyotypes, and pedigrees directly within the question stem rather than answering from memorized definitions alone. Pacing across six sections and roughly 6.5 hours of active testing means time management is itself a scoring factor: rushing the final section after over-deliberating early sections is a common, avoidable way to lose points that would otherwise be attainable.
Key Takeaway
Treat each of the six sections as its own mini-exam with its own pacing budget. Losing 10-15 minutes to one difficult section early on can compress your decision time on later sections and quietly erode your scaled score.
How Domain Weighting Shapes the Passing Threshold
The official 2026 blueprint allocates approximate percentages across 17 domains. Because the scaled score reflects performance across the entire blueprint, the domains with the largest weight naturally have the largest influence on whether you land above or below 500.
Domain 10: Solid Tumors (11%)
The single largest domain on the exam. Expect emphasis on actionable variants, resistance mutations, and molecular classification schemes used in solid tumor diagnosis and prognosis.
- Know which alterations drive targeted-therapy eligibility
- Distinguish diagnostic, prognostic, and predictive markers
Domain 8: Inherited Diseases (10%)
Second-largest domain. Candidates must move fluidly between pedigree analysis, inheritance patterns, and the molecular basis of single-gene and multifactorial disorders.
- Practice pedigree interpretation under time pressure
- Reinforce genotype-phenotype correlations for high-yield conditions
Domain 11: Hematopathology (9%)
Third-largest domain, covering molecular findings in myeloid and lymphoid neoplasms.
- Correlate cytogenetic and molecular findings with classification categories
- Distinguish clonal from reactive processes at the molecular level
Together, these three domains account for roughly 30% of the blueprint - meaning weak performance here has an outsized effect on your scaled score compared to lower-weight domains like Histocompatibility (2%) or Management and Informatics-General (3%). For a full breakdown of every content area, including the smaller domains that still require baseline competency, see the MGP Exam Domains 2026: Complete Guide to All 17 Content Areas.
| Domain | Approx. Weight | Scoring Impact |
|---|---|---|
| Solid Tumors | 11% | Highest single-domain leverage on scaled score |
| Inherited Diseases | 10% | Second-highest leverage |
| Hematopathology | 9% | Third-highest leverage |
| Normal Structure and Function | 7% | Moderate, foundational |
| Molecular Genetic Principles | 7% | Moderate, foundational |
| Assay Performance and Validation | 7% | Moderate, technical |
| Histocompatibility | 2% | Lowest individual leverage |
Skipping low-weight domains entirely is still risky, though - with 17 domains contributing to one aggregate scaled score, small gaps compound. A candidate who ignores Domain 15 (Histocompatibility, 2%) and Domain 17 (Management and Informatics-General, 3%) is giving up 5% of the blueprint for essentially no reason, since these areas are narrow enough to review efficiently.
What Recent Pass Rates Suggest About the Standard
ABPath's most recent reporting shows that in 2025, 50 of 56 examinees passed the MGP exam overall (89%), and 45 of 49 first-time examinees passed (92%). These figures suggest that the scaled-score-500 standard is achievable for well-prepared candidates who come through an ACGME-accredited fellowship pathway, but it is not a formality - a meaningful minority of examinees, including some first-timers, do not clear the bar.
The gap between the overall pass rate (89%) and the first-time pass rate (92%) is also worth noting: first-attempt candidates in 2025 actually passed at a slightly higher rate than the overall pool, which includes repeat examinees. This pattern is consistent with a scaled scoring system that rewards fresh, comprehensive blueprint coverage over narrowly targeted re-study of previously missed content. For a deeper dive into these numbers and how they compare year over year, see MGP Pass Rate 2026: What the Data Shows.
Question Formats That Cost Points
Because the MGP exam uses single-best-answer multiple-choice questions built around written and practical material, most missed points don't come from not knowing a fact - they come from misreading data presented in the stem. Three recurring failure patterns show up across candidates preparing for this exam:
- Conflating germline and somatic findings. A question may present a variant in a tumor sample and expect you to correctly classify it as somatic versus a coincidental germline finding requiring separate counseling implications.
- Misreading sequence or array output. Questions built around sequence traces, copy-number array plots, or karyotypes require you to extract the correct finding before you can even apply relevant knowledge - a wrong read guarantees a wrong answer regardless of your content mastery.
- Confusing infectious-disease molecular testing with germline/somatic testing logic. Domain 13 (Infectious Disease, 6%) uses different validation and interpretation logic than inherited disease or oncology testing, and candidates who apply the wrong framework lose points on otherwise familiar concepts.
Practicing with data-rich, blueprint-aligned questions - rather than pure recall flashcards - is the most direct way to reduce these errors before test day. The practice platform at MGP Exam Prep is built specifically around this kind of applied, data-interpretation question style.
Allocating Study Time Around the Scaled Score
Because the scaled score aggregates across all 17 domains, your study calendar should mirror the blueprint's weighting rather than your personal comfort level. A practical way to do this is to front-load the three heaviest domains, then work down through moderate-weight domains, reserving the final stretch for integration and timed practice.
Solid Tumors & Inherited Diseases
- Review actionable and resistance variants across major solid tumor types
- Drill pedigree interpretation and inheritance-pattern reasoning
Hematopathology & Molecular Genetic Principles
- Correlate cytogenetic/molecular findings with hematologic classification
- Reinforce core molecular biology underlying all downstream domains
Techniques, Assay Validation & Quality
- Review assay validation statistics and quality metrics
- Practice distinguishing laboratory-method questions from clinical-interpretation questions
Smaller Domains & Full Timed Practice
- Cover Pharmacogenetics, Infectious Disease, Identity Testing, Histocompatibility, Informatics
- Run full-length timed sections mimicking the 6-hour-34-minute active testing window
This is not a rigid template - candidates with fellowship strengths in certain areas should compress that section and redirect time toward weaker domains. For a more detailed week-by-week framework and first-attempt strategy, see the MGP Study Guide 2026: How to Pass on Your First Attempt.
Registration, Fees, and Test-Day Mechanics
Passing the scaled-score threshold starts well before test day with correct eligibility and registration. Through the ABPath application route, the 2026 initial application/examination fee is USD 2,100, which includes a USD 200 nonrefundable administrative fee. Eligibility requires a qualifying primary ABPath certification (AP/CP, AP, or CP) or eligible ABMGG physician certification, plus 12 months of ACGME-accredited Molecular Genetic Pathology fellowship training, along with applicable medical education, licensure, and training-verification requirements.
Because testing occurs in person at Pearson VUE Professional Centers - not remotely - candidates should plan travel and scheduling well in advance of the testing window rather than assuming last-minute flexibility. For the full breakdown of fees, refund policies, and what's included, see MGP Certification Cost 2026: Complete Pricing Breakdown, and for eligibility specifics, review MGP Requirements 2026: Eligibility, Prerequisites & How to Qualify. Exact registration windows and deadlines are covered in MGP Exam Dates 2026: Testing Windows, Deadlines & Scheduling.
If you're still weighing whether the fellowship time and exam investment make sense for your career path, Is the MGP Certification Worth It? Complete ROI Analysis 2026 and MGP Salary Guide 2026: Complete Earnings Analysis cover the broader career context, while MGP Jobs outlines the kinds of positions that value this credential.
Before your final review push, run through a condensed reference like the MGP Cheat Sheet 2026: One-Page Review of Must-Know Facts and practice full timed forms on MGP Exam Prep to build familiarity with the pacing demands of a 245-question, six-section exam.
Frequently Asked Questions
There is no published raw-score cutoff. ABPath converts raw performance to a scaled score, and passing requires a scaled score of 500, which accounts for differences in difficulty between exam forms.
ABPath does not publish domain-by-domain minimum thresholds; the scaled score reflects performance across the full blueprint. However, because Solid Tumors, Inherited Diseases, and Hematopathology carry the highest weights, weak performance there has a greater effect on your overall scaled score.
The 2026 form has 245 questions across six sections, with 6 hours 34 minutes of active testing time within a 9 hour 4 minute total scheduled day that includes instructions, a survey, and breaks.
No. The exam is administered in person at Pearson VUE Professional Centers; it is not offered as a remotely proctored at-home test.
Your certificate has no fixed expiration date, but continued standing depends on ABPath's Continuing Certification requirements, including biennial PATHway reporting, 70 CME credits per two-year period, and quarterly ABPath CertLink assessments with a four-year cumulative performance requirement of at least 60%.
Ready to pass your MGP exam?
Put this into practice with free MGP questions across every exam domain.